Is NLTX or DIVO a better dividend investment in 2026?

NLTX currently yields 57.31% with a 5% 5-year dividend growth rate. DIVO yields 6.49% with 5% growth. The better choice depends on your goal: NLTX offers higher current income.

What is the dividend yield difference between NLTX and DIVO?

NLTX has a forward dividend yield of 57.31% ($2.00/share annually). DIVO yields 6.49% ($2.91/share annually). The yield gap is 50.82 percentage points.

Home › Compare › NLTX vs DIVO

NLTX vs DIVO: Dividend Comparison 2026

NLTX yields 57.31% · DIVO yields 6.49%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 NLTX wins by $539.7K in total portfolio value

INVESTMENT

TIME HORIZON10 years

NLTX

● Live price

57.31%

Share price

$3.49

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$570.4K

Annual income

$128,685.50

Full NLTX calculator →

DIVO

● Live price

6.49%

Share price

$44.85

Annual div

$2.91

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$30.7K

Annual income

$981.68

Full DIVO calculator →

Portfolio growth — NLTX vs DIVO

📍 NLTX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	NLTX	DIVO
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, NLTX + DIVO cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

NLTX pays

DIVO pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NLTX

Annual income on $10K today (after 15% tax)

$4,871.06/yr

After 10yr DRIP, annual income (after tax)

$109,382.68/yr

DIVO

Annual income on $10K today (after 15% tax)

$552.00/yr

After 10yr DRIP, annual income (after tax)

$834.43/yr

At 15% tax rate, NLTX beats the other by $108,548.25/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NLTX + DIVO for your $10,000?

NLTX: 50%DIVO: 50%

100% DIVO50/50100% NLTX

Portfolio after 10yr

$300.6K

Annual income

$64,833.59/yr

Blended yield

21.57%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on NLTX right now

NLTX

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Altman Z

-1.6

Piotroski

3/9

DIVO

No analyst data

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NLTX buys

DIVO buys

No recent congressional trades found for NLTX or DIVO in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricNLTXDIVO

Forward yield	57.31% ✓	6.49%
Annual dividend / share	$2.00	$2.91 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$570.4K ✓	$30.7K
Annual income after 10y	$128,685.50 ✓	$981.68
Total dividends collected	$468.8K ✓	$8.2K
Payment frequency	quarterly	quarterly
Sector	Stock	ETF

Year-by-year: NLTX vs DIVO ($10,000, DRIP)

Year	NLTX Portfolio	NLTX Income/yr	DIVO Portfolio	DIVO Income/yr	Gap
1← crossover	$16,431	$5,730.66	$11,349	$649.42	+$5.1K → NLTX
2	$26,381	$8,799.86	$12,833	$688.83	+$13.5K → NLTX
3	$41,432	$13,204.52	$14,459	$727.90	+$27.0K → NLTX
4	$63,714	$19,381.50	$16,238	$766.49	+$47.5K → NLTX
5	$96,028	$27,854.89	$18,179	$804.47	+$77.8K → NLTX
6	$141,986	$39,236.06	$20,293	$841.71	+$121.7K → NLTX
7	$206,144	$54,218.66	$22,591	$878.14	+$183.6K → NLTX
8	$294,142	$73,568.04	$25,087	$913.65	+$269.1K → NLTX
9	$412,837	$98,105.15	$27,791	$948.18	+$385.0K → NLTX
10	$570,422	$128,685.50	$30,718	$981.68	+$539.7K → NLTX

NLTX vs DIVO: Complete Analysis 2026

NLTX — Stock

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

Full NLTX Calculator →

DIVO — ETF

DIVO is an ETF of high-quality large cap companies with a history of dividend and earnings growth, along with a tactical covered call* strategy on individual stocks. DIVO is strategically designed to offer high levels of total return on a risk-adjusted basis.

Full DIVO Calculator →

📬

Get this NLTX vs DIVO comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NLTX vs SCHD NLTX vs JEPI NLTX vs O NLTX vs KO NLTX vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.